Lili Huang
Guangdong Pharmaceutical University(CN)Guangzhou Center for Disease Control and Prevention(CN)Henan Provincial Center for Disease Control and Prevention(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Respiratory viral infections research, Herpesvirus Infections and Treatments, Pneumonia and Respiratory Infections
Most-Cited Works
- → Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial(2020)1,207 cited
- → Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes(2020)803 cited
- → Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial(2021)198 cited
- → The impact of the catastrophic earthquake in China's Sichuan province on the mental health of pregnant women(2011)71 cited
- → Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial(2021)40 cited
- → Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial